Michael Hallek to Models, Biological
This is a "connection" page, showing publications Michael Hallek has written about Models, Biological.
Connection Strength
0.261
-
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. Blood. 2018 03 01; 131(9):955-962.
Score: 0.206
-
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Leuk Lymphoma. 2019 06; 60(6):1438-1446.
Score: 0.055